
How I Manage My Pain – Pain Series Part 3 of 3
This is Part 3 of three articles I wrote about pain. The first 2 are entitled: Part 1- The real impact of pain that people


This is Part 3 of three articles I wrote about pain. The first 2 are entitled: Part 1- The real impact of pain that people

My journey with cardiac amyloidosis started shortly after I retired as a firefighter/paramedic in spring 2018. I started with trigger fingers—one in 2018 and two

While surgery has long been the standard for removing solid tumors, a revolutionary technique called histotripsy is offering an alternative, as reported on MedPage Today.

Remix Therapeutics has achieved a significant regulatory milestone with the U.S. Food and Drug Administration granting Fast Track designation to REM-422, a first-in-class small molecule

My whole life growing up, there was this specific buzzing sound that would come alive on the sunniest of days. I’ve been told over the

On 12/12/2025, I was admitted into the ER for a thrombectomy due to a bilateral pulmonary embolism. While I am overweight and sometimes eat like

The American Nutrition Association (ANA) has announced a collaborative initiative with Jazz Pharmaceuticals designed to advance evidence-based nutritional education for individuals living with narcolepsy and

This patient story is sponsored by Chiesi Global Rare Diseases and is promoted through the Patient Worthy Collaborative Content program. We only publish content that

Patients living with chronic or rare diseases and the caregivers coordinating appointments, medications, and daily life often carry a quiet question alongside the medical work:

The Dravet Syndrome Foundation of Spain hosted its 2026 Annual Family Meeting on March 20 at the Rafaela Ybarra School in Madrid, bringing together roughly 100

The pharmaceutical industry celebrates a significant victory for rare disease patients as the Food and Drug Administration approved Denali Therapeutics’ groundbreaking enzyme replacement therapy for

As reported on PharmaBiz, the US Food and Drug Administration (FDA) has approved Novo Nordisk’s higher‑dose formulation of semaglutide, Wegovy HD (7.2 mg once weekly),

I used to be really active: swimming, Tai Chi every week, practicing yoga. So, when I first felt persistent rib and back pain in late

GSK has announced a significant advancement in liver disease treatment with FDA approval of Lynavoy (linerixibat), marking the first medication specifically approved in the United

My diagnosis of rheumatic heart disease came on suddenly. I remember being 12, sitting at the doctor’s office, and was told that I have a

Researchers at Florida Atlantic University (FAU) have identified a cellular pathway that allows brain cells to share proteins and other toxic material. The study was

Lupin, a globally recognized pharmaceutical company, has achieved a significant regulatory milestone with the receipt of tentative FDA approval for Pitolisant tablets in strengths of

Editor’s Note: Patient Worthy is honored to present this article, shared with us by our friends at the Steatotic Liver Foundation (formerly the Fatty Liver
Bohring-Optiz Syndrome (BOS) is a rare genetic disorder that impacts growth and development, often associated with feeding difficulties, developmental delays, and distinct physical characteristics. While uncommon, it has a profound impact on individuals and families within the BOS community.
Observed annually on April 6th, Bohring-Optiz Syndrome Awareness Day is dedicated to increasing understanding, supporting affected families, and advancing research. By raising awareness, we help foster greater recognition, compassion, and process toward improved care and outcomes.
Share your rare disease journey and inspire others here: bit.ly/4dV7gru
#bohring-OptizSyndrome #BOSAwarenessDay #PatientWorthy
... See MoreSee Less


+4
Throughout the week, Patient Worthy is highlighting HIV with educational content aimed at raising awareness and fostering greater understanding in our community.
We’ll be sharing information on our socials and patientworthy.com to educate, empower, and support those affected.
If you'd like to share your story with HIV, click here: bit.ly/4dV7gru
#HumanImmunodeficiencyVirus #HIV #HIVAwareness #ShareYourStory #PatientWorthy
... See MoreSee Less

April 5th is Barth Syndrome Awareness Day - a time to shine a light on a rare genetic condition that affects the heart, muscles, and immune system. Barth Syndrome may be a little known, but for those living with it, the challenges are very real. Raising Awareness helps drive research, early diagnosis, and support for families who need it most.
Every voice matters. By learning, sharing, and advocating, we can help create a future where rare diseases like this are better understood and treated. #barthsyndromeawareness #geneticdisorders #PatientWorthy
... See MoreSee Less

© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.